Oncodesign Precision Medicine (XPAR:ALOPM) Selling, General, & Admin. Expense : € Mil (TTM As of Jun. 2022)

Oncodesign Precision Medicine Selling, General, & Admin. Expense Chart

Competitive Comparison of Oncodesign Precision Medicine's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Oncodesign Precision Medicine's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Selling, General, & Admin. Expense falls into.

Oncodesign Precision Medicine Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Oncodesign Precision Medicine  (XPAR:ALOPM) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.

Oncodesign Precision Medicine Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description